Autolus Therapeutics plc announced that Dr. William D. Young, a Senior Advisor to Blackstone Life Sciences, has been appointed as a non-executive director to its board of directors, with effect from November 15, 2021. The appointment is pursuant to the recently announced investment from Blackstone Life Sciences. Dr. Young will serve as a Class III director, with an initial term expiring at Autolus? 2024 annual general meeting. Dr. Young brings to Autolus more than 50 years of experience in the life science industry, most notably prior service as Chief Operating Officer of Genentech and Chairman of the Board of Biogen. Prior to his current role as senior advisor to Blackstone Life Sciences, he served as the Chief Executive Officer of Monogram Biosciences, which was acquired by Laboratory Corporation of America in 2009.